CCL5 and melanoma: Moreover, the post‐treatment tumor tissues of responders exhibited higher CCL5 expression than those of non‐responders in patients with melanoma (GSE91061), gastric cancer (PRJEB25780), and non‐small cell lung cancer (GSE135222) (Figure 8B).